1. Home
  2. AVDL vs SCHL Comparison

AVDL vs SCHL Comparison

Compare AVDL & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • SCHL
  • Stock Information
  • Founded
  • AVDL 2015
  • SCHL 1920
  • Country
  • AVDL Ireland
  • SCHL United States
  • Employees
  • AVDL N/A
  • SCHL N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • SCHL Books
  • Sector
  • AVDL Health Care
  • SCHL Consumer Discretionary
  • Exchange
  • AVDL Nasdaq
  • SCHL Nasdaq
  • Market Cap
  • AVDL 993.5M
  • SCHL 838.6M
  • IPO Year
  • AVDL 1996
  • SCHL 1987
  • Fundamental
  • Price
  • AVDL $10.48
  • SCHL $21.14
  • Analyst Decision
  • AVDL Strong Buy
  • SCHL
  • Analyst Count
  • AVDL 6
  • SCHL 0
  • Target Price
  • AVDL $24.00
  • SCHL N/A
  • AVG Volume (30 Days)
  • AVDL 1.1M
  • SCHL 334.9K
  • Earning Date
  • AVDL 11-12-2024
  • SCHL 12-19-2024
  • Dividend Yield
  • AVDL N/A
  • SCHL 3.67%
  • EPS Growth
  • AVDL N/A
  • SCHL N/A
  • EPS
  • AVDL N/A
  • SCHL N/A
  • Revenue
  • AVDL $138,160,000.00
  • SCHL $1,580,400,000.00
  • Revenue This Year
  • AVDL $523.86
  • SCHL $6.25
  • Revenue Next Year
  • AVDL $70.46
  • SCHL $4.85
  • P/E Ratio
  • AVDL N/A
  • SCHL N/A
  • Revenue Growth
  • AVDL 1523.50
  • SCHL N/A
  • 52 Week Low
  • AVDL $9.41
  • SCHL $19.14
  • 52 Week High
  • AVDL $19.09
  • SCHL $40.74
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 46.37
  • SCHL 37.13
  • Support Level
  • AVDL $9.97
  • SCHL $19.14
  • Resistance Level
  • AVDL $10.53
  • SCHL $25.77
  • Average True Range (ATR)
  • AVDL 0.47
  • SCHL 1.13
  • MACD
  • AVDL 0.12
  • SCHL -0.44
  • Stochastic Oscillator
  • AVDL 61.43
  • SCHL 35.42

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

Share on Social Networks: